0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Delivery System for Inhaled Nitric Oxide Therapy Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-35S14731
Home | Market Reports | Health| Medical Devices & Equipment
Global Delivery System for Inhaled Nitric Oxide Therapy Market Research Report 2023
BUY CHAPTERS

Global Delivery System for Inhaled Nitric Oxide Therapy Market Research Report 2025

Code: QYRE-Auto-35S14731
Report
May 2025
Pages:69
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Delivery System for Inhaled Nitric Oxide Therapy Market Size

The global market for Delivery System for Inhaled Nitric Oxide Therapy was valued at US$ 451 million in the year 2024 and is projected to reach a revised size of US$ 768 million by 2031, growing at a CAGR of 8.0% during the forecast period.

Delivery System for Inhaled Nitric Oxide Therapy Market

Delivery System for Inhaled Nitric Oxide Therapy Market

The main medical inhaled Nitric Oxide players include Mallinckrodt, Linde, Air Liquide, etc. The top three Medical Inhaled Nitric Oxide players account for approximately 95% of the total global market. The global medical inhaled Nitric Oxide are mainly produced in United States and Europe, they occupied for a share about 95%. North America is the largest consumer market, accounting for about 77%, followed by Europe and Asia-Pacific, with around 16% and 6% market share respectively.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Delivery System for Inhaled Nitric Oxide Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Delivery System for Inhaled Nitric Oxide Therapy.
The Delivery System for Inhaled Nitric Oxide Therapy market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Delivery System for Inhaled Nitric Oxide Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Delivery System for Inhaled Nitric Oxide Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Delivery System for Inhaled Nitric Oxide Therapy Market Report

Report Metric Details
Report Name Delivery System for Inhaled Nitric Oxide Therapy Market
Accounted market size in year US$ 451 million
Forecasted market size in 2031 US$ 768 million
CAGR 8.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • With Gas Cylinders
  • Without Gas Cylinders
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company VERO Biotech, Linde plc., Mallinckrodt, Air Liquide Healthcare, NOxBOX
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Delivery System for Inhaled Nitric Oxide Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Delivery System for Inhaled Nitric Oxide Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Delivery System for Inhaled Nitric Oxide Therapy Market growing?

Ans: The Delivery System for Inhaled Nitric Oxide Therapy Market witnessing a CAGR of 8.0% during the forecast period 2025-2031.

What is the Delivery System for Inhaled Nitric Oxide Therapy Market size in 2031?

Ans: The Delivery System for Inhaled Nitric Oxide Therapy Market size in 2031 will be US$ 768 million.

What is the market share of major companies in Delivery System for Inhaled Nitric Oxide Therapy Market?

Ans: The top three Medical Inhaled Nitric Oxide players account for approximately 95% of the total global market.

What is the Delivery System for Inhaled Nitric Oxide Therapy Market share by region?

Ans: North America is the largest consumer market, accounting for about 77%, followed by Europe and Asia-Pacific, with around 16% and 6% market share respectively.

Who are the main players in the Delivery System for Inhaled Nitric Oxide Therapy Market report?

Ans: The main players in the Delivery System for Inhaled Nitric Oxide Therapy Market are VERO Biotech, Linde plc., Mallinckrodt, Air Liquide Healthcare, NOxBOX

What are the Application segmentation covered in the Delivery System for Inhaled Nitric Oxide Therapy Market report?

Ans: The Applications covered in the Delivery System for Inhaled Nitric Oxide Therapy Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Delivery System for Inhaled Nitric Oxide Therapy Market report?

Ans: The Types covered in the Delivery System for Inhaled Nitric Oxide Therapy Market report are With Gas Cylinders, Without Gas Cylinders

Recommended Reports

Inhaled Therapy Devices

Respiratory Therapy Systems

Medical Gas & Oxygen

1 Delivery System for Inhaled Nitric Oxide Therapy Market Overview
1.1 Product Definition
1.2 Delivery System for Inhaled Nitric Oxide Therapy by Type
1.2.1 Global Delivery System for Inhaled Nitric Oxide Therapy Market Value Comparison by Type (2024 VS 2031)
1.2.2 With Gas Cylinders
1.2.3 Without Gas Cylinders
1.3 Delivery System for Inhaled Nitric Oxide Therapy by Application
1.3.1 Global Delivery System for Inhaled Nitric Oxide Therapy Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Delivery System for Inhaled Nitric Oxide Therapy Market Size Estimates and Forecasts
1.4.1 Global Delivery System for Inhaled Nitric Oxide Therapy Revenue 2020-2031
1.4.2 Global Delivery System for Inhaled Nitric Oxide Therapy Sales 2020-2031
1.4.3 Global Delivery System for Inhaled Nitric Oxide Therapy Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Delivery System for Inhaled Nitric Oxide Therapy Market Competition by Manufacturers
2.1 Global Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Manufacturers (2020-2025)
2.2 Global Delivery System for Inhaled Nitric Oxide Therapy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Delivery System for Inhaled Nitric Oxide Therapy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Delivery System for Inhaled Nitric Oxide Therapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Delivery System for Inhaled Nitric Oxide Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Delivery System for Inhaled Nitric Oxide Therapy, Product Type & Application
2.7 Global Key Manufacturers of Delivery System for Inhaled Nitric Oxide Therapy, Date of Enter into This Industry
2.8 Global Delivery System for Inhaled Nitric Oxide Therapy Market Competitive Situation and Trends
2.8.1 Global Delivery System for Inhaled Nitric Oxide Therapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Delivery System for Inhaled Nitric Oxide Therapy Players Market Share by Revenue
2.8.3 Global Delivery System for Inhaled Nitric Oxide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Delivery System for Inhaled Nitric Oxide Therapy Market Scenario by Region
3.1 Global Delivery System for Inhaled Nitric Oxide Therapy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Delivery System for Inhaled Nitric Oxide Therapy Sales by Region: 2020-2031
3.2.1 Global Delivery System for Inhaled Nitric Oxide Therapy Sales by Region: 2020-2025
3.2.2 Global Delivery System for Inhaled Nitric Oxide Therapy Sales by Region: 2026-2031
3.3 Global Delivery System for Inhaled Nitric Oxide Therapy Revenue by Region: 2020-2031
3.3.1 Global Delivery System for Inhaled Nitric Oxide Therapy Revenue by Region: 2020-2025
3.3.2 Global Delivery System for Inhaled Nitric Oxide Therapy Revenue by Region: 2026-2031
3.4 North America Delivery System for Inhaled Nitric Oxide Therapy Market Facts & Figures by Country
3.4.1 North America Delivery System for Inhaled Nitric Oxide Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Delivery System for Inhaled Nitric Oxide Therapy Sales by Country (2020-2031)
3.4.3 North America Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Delivery System for Inhaled Nitric Oxide Therapy Market Facts & Figures by Country
3.5.1 Europe Delivery System for Inhaled Nitric Oxide Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Delivery System for Inhaled Nitric Oxide Therapy Sales by Country (2020-2031)
3.5.3 Europe Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Delivery System for Inhaled Nitric Oxide Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific Delivery System for Inhaled Nitric Oxide Therapy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales by Region (2020-2031)
3.6.3 Asia Pacific Delivery System for Inhaled Nitric Oxide Therapy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Delivery System for Inhaled Nitric Oxide Therapy Market Facts & Figures by Country
3.7.1 Latin America Delivery System for Inhaled Nitric Oxide Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Delivery System for Inhaled Nitric Oxide Therapy Sales by Country (2020-2031)
3.7.3 Latin America Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Delivery System for Inhaled Nitric Oxide Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Delivery System for Inhaled Nitric Oxide Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Delivery System for Inhaled Nitric Oxide Therapy Sales by Country (2020-2031)
3.8.3 Middle East and Africa Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Delivery System for Inhaled Nitric Oxide Therapy Sales by Type (2020-2031)
4.1.1 Global Delivery System for Inhaled Nitric Oxide Therapy Sales by Type (2020-2025)
4.1.2 Global Delivery System for Inhaled Nitric Oxide Therapy Sales by Type (2026-2031)
4.1.3 Global Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Type (2020-2031)
4.2 Global Delivery System for Inhaled Nitric Oxide Therapy Revenue by Type (2020-2031)
4.2.1 Global Delivery System for Inhaled Nitric Oxide Therapy Revenue by Type (2020-2025)
4.2.2 Global Delivery System for Inhaled Nitric Oxide Therapy Revenue by Type (2026-2031)
4.2.3 Global Delivery System for Inhaled Nitric Oxide Therapy Revenue Market Share by Type (2020-2031)
4.3 Global Delivery System for Inhaled Nitric Oxide Therapy Price by Type (2020-2031)
5 Segment by Application
5.1 Global Delivery System for Inhaled Nitric Oxide Therapy Sales by Application (2020-2031)
5.1.1 Global Delivery System for Inhaled Nitric Oxide Therapy Sales by Application (2020-2025)
5.1.2 Global Delivery System for Inhaled Nitric Oxide Therapy Sales by Application (2026-2031)
5.1.3 Global Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Application (2020-2031)
5.2 Global Delivery System for Inhaled Nitric Oxide Therapy Revenue by Application (2020-2031)
5.2.1 Global Delivery System for Inhaled Nitric Oxide Therapy Revenue by Application (2020-2025)
5.2.2 Global Delivery System for Inhaled Nitric Oxide Therapy Revenue by Application (2026-2031)
5.2.3 Global Delivery System for Inhaled Nitric Oxide Therapy Revenue Market Share by Application (2020-2031)
5.3 Global Delivery System for Inhaled Nitric Oxide Therapy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 VERO Biotech
6.1.1 VERO Biotech Company Information
6.1.2 VERO Biotech Description and Business Overview
6.1.3 VERO Biotech Delivery System for Inhaled Nitric Oxide Therapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 VERO Biotech Delivery System for Inhaled Nitric Oxide Therapy Product Portfolio
6.1.5 VERO Biotech Recent Developments/Updates
6.2 Linde plc.
6.2.1 Linde plc. Company Information
6.2.2 Linde plc. Description and Business Overview
6.2.3 Linde plc. Delivery System for Inhaled Nitric Oxide Therapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Linde plc. Delivery System for Inhaled Nitric Oxide Therapy Product Portfolio
6.2.5 Linde plc. Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Company Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Delivery System for Inhaled Nitric Oxide Therapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mallinckrodt Delivery System for Inhaled Nitric Oxide Therapy Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Air Liquide Healthcare
6.4.1 Air Liquide Healthcare Company Information
6.4.2 Air Liquide Healthcare Description and Business Overview
6.4.3 Air Liquide Healthcare Delivery System for Inhaled Nitric Oxide Therapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Air Liquide Healthcare Delivery System for Inhaled Nitric Oxide Therapy Product Portfolio
6.4.5 Air Liquide Healthcare Recent Developments/Updates
6.5 NOxBOX
6.5.1 NOxBOX Company Information
6.5.2 NOxBOX Description and Business Overview
6.5.3 NOxBOX Delivery System for Inhaled Nitric Oxide Therapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 NOxBOX Delivery System for Inhaled Nitric Oxide Therapy Product Portfolio
6.5.5 NOxBOX Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Delivery System for Inhaled Nitric Oxide Therapy Industry Chain Analysis
7.2 Delivery System for Inhaled Nitric Oxide Therapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Delivery System for Inhaled Nitric Oxide Therapy Production Mode & Process Analysis
7.4 Delivery System for Inhaled Nitric Oxide Therapy Sales and Marketing
7.4.1 Delivery System for Inhaled Nitric Oxide Therapy Sales Channels
7.4.2 Delivery System for Inhaled Nitric Oxide Therapy Distributors
7.5 Delivery System for Inhaled Nitric Oxide Therapy Customer Analysis
8 Delivery System for Inhaled Nitric Oxide Therapy Market Dynamics
8.1 Delivery System for Inhaled Nitric Oxide Therapy Industry Trends
8.2 Delivery System for Inhaled Nitric Oxide Therapy Market Drivers
8.3 Delivery System for Inhaled Nitric Oxide Therapy Market Challenges
8.4 Delivery System for Inhaled Nitric Oxide Therapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Delivery System for Inhaled Nitric Oxide Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Delivery System for Inhaled Nitric Oxide Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Delivery System for Inhaled Nitric Oxide Therapy Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Delivery System for Inhaled Nitric Oxide Therapy Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Delivery System for Inhaled Nitric Oxide Therapy Average Price (K US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Delivery System for Inhaled Nitric Oxide Therapy, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Delivery System for Inhaled Nitric Oxide Therapy, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Delivery System for Inhaled Nitric Oxide Therapy, Product Type & Application
 Table 12. Global Key Manufacturers of Delivery System for Inhaled Nitric Oxide Therapy, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Delivery System for Inhaled Nitric Oxide Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Delivery System for Inhaled Nitric Oxide Therapy as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Delivery System for Inhaled Nitric Oxide Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Delivery System for Inhaled Nitric Oxide Therapy Sales by Region (2020-2025) & (Units)
 Table 18. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Region (2020-2025)
 Table 19. Global Delivery System for Inhaled Nitric Oxide Therapy Sales by Region (2026-2031) & (Units)
 Table 20. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Region (2026-2031)
 Table 21. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue Market Share by Region (2020-2025)
 Table 23. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue Market Share by Region (2026-2031)
 Table 25. North America Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Delivery System for Inhaled Nitric Oxide Therapy Sales by Country (2020-2025) & (Units)
 Table 27. North America Delivery System for Inhaled Nitric Oxide Therapy Sales by Country (2026-2031) & (Units)
 Table 28. North America Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Delivery System for Inhaled Nitric Oxide Therapy Sales by Country (2020-2025) & (Units)
 Table 32. Europe Delivery System for Inhaled Nitric Oxide Therapy Sales by Country (2026-2031) & (Units)
 Table 33. Europe Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Delivery System for Inhaled Nitric Oxide Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Delivery System for Inhaled Nitric Oxide Therapy Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Delivery System for Inhaled Nitric Oxide Therapy Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Delivery System for Inhaled Nitric Oxide Therapy Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Delivery System for Inhaled Nitric Oxide Therapy Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Delivery System for Inhaled Nitric Oxide Therapy Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Delivery System for Inhaled Nitric Oxide Therapy Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Delivery System for Inhaled Nitric Oxide Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Delivery System for Inhaled Nitric Oxide Therapy Sales (Units) by Type (2020-2025)
 Table 51. Global Delivery System for Inhaled Nitric Oxide Therapy Sales (Units) by Type (2026-2031)
 Table 52. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Type (2020-2025)
 Table 53. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Type (2026-2031)
 Table 54. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue Market Share by Type (2020-2025)
 Table 57. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue Market Share by Type (2026-2031)
 Table 58. Global Delivery System for Inhaled Nitric Oxide Therapy Price (K US$/Unit) by Type (2020-2025)
 Table 59. Global Delivery System for Inhaled Nitric Oxide Therapy Price (K US$/Unit) by Type (2026-2031)
 Table 60. Global Delivery System for Inhaled Nitric Oxide Therapy Sales (Units) by Application (2020-2025)
 Table 61. Global Delivery System for Inhaled Nitric Oxide Therapy Sales (Units) by Application (2026-2031)
 Table 62. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Application (2020-2025)
 Table 63. Global Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Application (2026-2031)
 Table 64. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue Market Share by Application (2020-2025)
 Table 67. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue Market Share by Application (2026-2031)
 Table 68. Global Delivery System for Inhaled Nitric Oxide Therapy Price (K US$/Unit) by Application (2020-2025)
 Table 69. Global Delivery System for Inhaled Nitric Oxide Therapy Price (K US$/Unit) by Application (2026-2031)
 Table 70. VERO Biotech Company Information
 Table 71. VERO Biotech Description and Business Overview
 Table 72. VERO Biotech Delivery System for Inhaled Nitric Oxide Therapy Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 73. VERO Biotech Delivery System for Inhaled Nitric Oxide Therapy Product
 Table 74. VERO Biotech Recent Developments/Updates
 Table 75. Linde plc. Company Information
 Table 76. Linde plc. Description and Business Overview
 Table 77. Linde plc. Delivery System for Inhaled Nitric Oxide Therapy Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 78. Linde plc. Delivery System for Inhaled Nitric Oxide Therapy Product
 Table 79. Linde plc. Recent Developments/Updates
 Table 80. Mallinckrodt Company Information
 Table 81. Mallinckrodt Description and Business Overview
 Table 82. Mallinckrodt Delivery System for Inhaled Nitric Oxide Therapy Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 83. Mallinckrodt Delivery System for Inhaled Nitric Oxide Therapy Product
 Table 84. Mallinckrodt Recent Developments/Updates
 Table 85. Air Liquide Healthcare Company Information
 Table 86. Air Liquide Healthcare Description and Business Overview
 Table 87. Air Liquide Healthcare Delivery System for Inhaled Nitric Oxide Therapy Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 88. Air Liquide Healthcare Delivery System for Inhaled Nitric Oxide Therapy Product
 Table 89. Air Liquide Healthcare Recent Developments/Updates
 Table 90. NOxBOX Company Information
 Table 91. NOxBOX Description and Business Overview
 Table 92. NOxBOX Delivery System for Inhaled Nitric Oxide Therapy Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 93. NOxBOX Delivery System for Inhaled Nitric Oxide Therapy Product
 Table 94. NOxBOX Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Delivery System for Inhaled Nitric Oxide Therapy Distributors List
 Table 98. Delivery System for Inhaled Nitric Oxide Therapy Customers List
 Table 99. Delivery System for Inhaled Nitric Oxide Therapy Market Trends
 Table 100. Delivery System for Inhaled Nitric Oxide Therapy Market Drivers
 Table 101. Delivery System for Inhaled Nitric Oxide Therapy Market Challenges
 Table 102. Delivery System for Inhaled Nitric Oxide Therapy Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Delivery System for Inhaled Nitric Oxide Therapy
 Figure 2. Global Delivery System for Inhaled Nitric Oxide Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Delivery System for Inhaled Nitric Oxide Therapy Market Share by Type: 2024 & 2031
 Figure 4. With Gas Cylinders Product Picture
 Figure 5. Without Gas Cylinders Product Picture
 Figure 6. Global Delivery System for Inhaled Nitric Oxide Therapy Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Delivery System for Inhaled Nitric Oxide Therapy Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Delivery System for Inhaled Nitric Oxide Therapy Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Delivery System for Inhaled Nitric Oxide Therapy Sales (2020-2031) & (Units)
 Figure 14. Global Delivery System for Inhaled Nitric Oxide Therapy Average Price (K US$/Unit) & (2020-2031)
 Figure 15. Delivery System for Inhaled Nitric Oxide Therapy Report Years Considered
 Figure 16. Delivery System for Inhaled Nitric Oxide Therapy Sales Share by Manufacturers in 2024
 Figure 17. Global Delivery System for Inhaled Nitric Oxide Therapy Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Delivery System for Inhaled Nitric Oxide Therapy Players: Market Share by Revenue in Delivery System for Inhaled Nitric Oxide Therapy in 2024
 Figure 19. Delivery System for Inhaled Nitric Oxide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Delivery System for Inhaled Nitric Oxide Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Country (2020-2031)
 Figure 22. North America Delivery System for Inhaled Nitric Oxide Therapy Revenue Market Share by Country (2020-2031)
 Figure 23. United States Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Country (2020-2031)
 Figure 26. Europe Delivery System for Inhaled Nitric Oxide Therapy Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Delivery System for Inhaled Nitric Oxide Therapy Revenue Market Share by Region (2020-2031)
 Figure 34. China Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Delivery System for Inhaled Nitric Oxide Therapy Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Delivery System for Inhaled Nitric Oxide Therapy Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Delivery System for Inhaled Nitric Oxide Therapy Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Delivery System for Inhaled Nitric Oxide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Delivery System for Inhaled Nitric Oxide Therapy by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Delivery System for Inhaled Nitric Oxide Therapy by Type (2020-2031)
 Figure 53. Global Delivery System for Inhaled Nitric Oxide Therapy Price (K US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Delivery System for Inhaled Nitric Oxide Therapy by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Delivery System for Inhaled Nitric Oxide Therapy by Application (2020-2031)
 Figure 56. Global Delivery System for Inhaled Nitric Oxide Therapy Price (K US$/Unit) by Application (2020-2031)
 Figure 57. Delivery System for Inhaled Nitric Oxide Therapy Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart